Abstract:Abstract Background Liver cancer is among the most common malignancy worldwide. Hepatocellular carcinoma (HCC), the principal histological subtype of liver cancer, is globally the third most common cause of cancer-related mortality. The high rates of recurrence and metastasis contribute to the poor prognosis of HCC patients. In recent years, increasing evidence has shown that microRNAs (miRNAs) are involved in the tumorigenesis, progression, and prognosis of HCC. Methods To screen for key candidate miRNAs in HCC, three microarray datasets were downloaded from Gene Expression Omnibus (GEO). The sole common differentially expressed miRNA (DEmiR) observed in the above three datasets using a Venn diagram was microRNA-211-5p (miR-211-5p). The expression of miR-211-5p from HCC tissues was measured in several HCC cell lines. Additionally, using Kaplan–Meier plots, the potential prognostic value of miR-211-5p in HCC was analyzed. Cell counting kit-8 (CCK-8) and transwell assays examined the ability of miR-211-5p to induce cell proliferation, migration, and invasion in HCC cultures. The interaction of miR-211-5p and Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) was assessed both theoretically and using a luciferase reporter assay. Finally, the ability of miR-211-5p to modulate tumorigenesis in HCC in vivo was assessed after establishing a xenograft model. Results qRT-PCR demonstrated that the relative expression of miR-211-5p was considerably down-regulated in HCC tissues and cell lines compared with normal tissue. Kaplan–Meier plots indicated that HCC patients with decreased expression of miR-211-5p had poor overall survival. Upregulation of miR-211-5p in vitro consistently suppressed cell proliferation, migration, and invasion. In contrast, enhanced expression of ACSL4 promoted a malignant phenotype in HCC cells. Importantly, we discovered that ACSL4 was a direct downstream target of miR-211-5p in HCC, and that miR-211-5p suppressed the malignant phenotype by inhibition of ACSL4 expression. Furthermore, miR-211-5p overexpression impaired tumorigenesis and growth of HCC in vivo. Conclusions Targeting miR-211-5p and the downstream gene ACSL4 will possibly provide novel insight and represents a promising approach to future therapy of HCC patients.

miR-3154 promotes hepatocellular carcinoma progression via suppressing HNF4α

MiR-144-3p-mediated Dysregulation of EIF4G2 Contributes to the Development of Hepatocellular Carcinoma Through the ERK Pathway

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.

MicroRNA-301a-3p Suppressed the Progression of Hepatocellular Carcinoma Via Targeting VGLL4.

MicroRNA‐301b‐3p Contributes to Tumour Growth of Human Hepatocellular Carcinoma by Repressing Vestigial Like Family Member 4

Hepatocyte Nuclear Factor-4Α Reverses Malignancy of Hepatocellular Carcinoma Through Regulating Mir-134 in the DLK1-DIO3 Region.

Mir-1204 Promotes Hepatocellular Carcinoma Progression Through Activating MAPK and C-Jun/ap1 Signaling by Targeting ZNF418

MiR-324-3p Promotes Tumor Growth Through Targeting DACT1 and Activation of Wnt/β-catenin Pathway in Hepatocellular Carcinoma

MicroRNA-183-5p Contributes to Malignant Progression Through Targeting PDCD4 in Human Hepatocellular Carcinoma.

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.

Hepatocyte Nuclear Factor 4 Alpha-Nuclear Factor-Kappa B Feedback Circuit Modulates Liver Cancer Progression

MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1

MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2.

MicroRNA-1405 p suppresses tumor growth and metastasis by targeting TGFBR 1 and FGF 9 in Hepatocellular carcinoma

Mir-219 Regulates Liver Cancer Stem Cell Expansion Via E-cadherin Pathway.

LINC01535 promotes hepatocellular carcinoma proliferation and metastasis by regulating the miR-214-3p/VASP axis

Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

Klf4 Inhibits Tumor Growth and Metastasis by Targeting Microrna-31 in Human Hepatocellular Carcinoma

MiR-429 Increases the Metastatic Capability of HCC Via Regulating Classic Wnt Pathway Rather Than Epithelial–mesenchymal Transition

MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis